Johnson & Johnson offers to pay $6.5 billion to settle talc ovarian cancer lawsuits
[ad_1]
Johnson & Johnson said Wednesday it has offered to pay $6.5 billion to settle allegations that its talc products caused cancer, a key step in the pharmaceutical giant potentially resolving decades of litigation over what was once one of the most widely used consumer products in the U.S. The proposal is aimed at ending a protracted legal battle stemming from thousands of lawsuits that accused J&J of selling products that allegedly led women to develop ovarian cancer, in some cases causing their death. J&J maintains that its talc products are safe . But the company stopped selling talc-based items in 2020, and two years later announced plans to cease sales of the product worldwide. The company said the proposal would settle 99.75% of the pending talc lawsuits in the U.S. The legal actions not covered by the proposal relate to mesothelioma, a rare cancer that affects the lungs and other organs. The company said